Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Eur J Endocrinol. 2013 Nov 29;170(1):151–160. doi: 10.1530/EJE-13-0740

Table 3.

Clinical and mutational summaries of groups of confirmed or suspected PPNAD. Details on the clinical definition of each group are described in the ‘Subjects and methods’ section.

n Age Sex (M/F) PRKAR1A
mutation
PRKAR1A
deletion
PDE11A
mutation
Confirmed PPNAD 39 28±15 5/33 13 0 4
Suspected PPNAD 14 34±17 2/12 1 0 1